Latest Organelles Stories
A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine think could be prevented with new medicines. Now, the researchers are one step closer to achieving that goal, thanks to their discovery of a key molecule in an unexpected place in heart cells – mitochondria, tiny energy factories that house the controls capable of setting off cells' self-destruct...
Protein spheres in the nucleus give wrong signal for cell division A new hypothesis has been developed by researchers in Bochum on how Alzheimer's disease could occur. They analyzed the interaction of the proteins FE65 and BLM that regulate cell division. In the cell culture model, they discovered spherical structures in the nucleus that contained FE65 and BLM. The interaction of the proteins triggered a wrong signal for cell division. This may explain the degeneration and death of nerve...
Brett Smith for redOrbit.com - Your Universe Online If you’ve ever had a hard time getting motivated to go to the gym or get off the couch and head outside for a jog, it could be your genetics. According to a new study in the American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, a team of Missouri researchers were able to selectively breed rats that had either an active or lazy disposition. “We have shown that it is possible to be genetically...
NEW YORK, April 8, 2013 /PRNewswire/ -- Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostics for use in personalized medicine, today announced that the company is presenting a late-breaking abstract at the AACR Annual Meeting 2013, in Washington D.C. The abstract is titled "Exosome profiling of mRNAs and miRNAs in serum samples from GBM (glioblastoma multiforme) patients." It will be presented during Poster Session 47 from 1 to 5 p.m. EDT on April 8 by...
Exosomes and Microvesicles, the Official Journal of the American Society for Exosomes and Microvesicles, to Provide Scientific Community New Access to Ground-Breaking Research RIJEKA, Croatia, April 8, 2013 /PRNewswire/ -- InTech Open Access publisher is pleased to announce the collaboration with the American Society for Exosomes and Microvesicles (ASEMV) to publish the scientific journal Exosomes and Microvesicles, a peer-reviewed publication designed to bring together exosomes...
In a first-of-its-kind experiment using microvesicles generated from mesenchymal bone marrow cells (MSCs) to treat cancer, neurological researchers at Henry Ford Hospital have discovered a novel approach for treatment of tumors. Specifically, the research team found that introducing genetic material produced by MSCs significantly reduced a particularly resistant form of malignant brain tumor in living lab rats. Detroit, Michigan (PRWEB) April 01, 2013 DETROIT – In a first-of-its-kind...
New England Peptide acquires next generation exosome and microvesicle affinity technology for potential detection of cancer and other diseases. Gardner, MA (PRWEB) March 07, 2013 New England Peptide, Inc. (NEP) today announced that it has entered into a licensing agreement with the Atlantic Cancer Research Institute (ACRI). Under the terms of the agreement NEP has acquired the worldwide exclusive rights for Vn96 and a portfolio of other peptide compounds to be used for the research grade...
SAN DIEGO, Feb. 28, 2013 /PRNewswire/ --Aethlon Medical, Inc. (OTCQB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce. I recently attended a healthcare related event that featured a panel discussion comprised of life science bankers and venture capitalists. While members of this panel often had differing viewpoints, they did mutually agree they were interested in emerging therapeutic candidates that provided more than one "shot on goal," meaning...
LUND, Sweden, February 1, 2013 /PRNewswire/ -- NeuroVive, a leading mitochondrial medicine company, is pleased to announce the appointment of Jan Nilsson as Chief Operating Officer (COO). Jan will oversee the day-to-day operations of the Company and support the planned commercialisation of CicloMulsion(R) and NeuroSTAT(R), NeuroVive's leading products for the treatment of acute cardiovascular and neurological conditions through mitochondrial protection. Jan has over 30...
A new way of looking at a cell's surface reveals the distribution of small molecules in the cell membrane, changing the understanding of its organization. A novel imaging study by researchers from Lawrence Livermore National Laboratory, the University of Illinois and the National Institutes of Health revealed some unexpected relationships among molecules within cell membranes. Their findings provide a new way of studying cell structure and ultimately its function. Led by Mary Kraft...
